Synopsis of recent research by authors named "Xinghuan Li"
- Xinghuan Li's recent research encompasses a variety of medical topics, including the efficacy of PCSK9 inhibitors in treating hypercholesterolemia, cost-effectiveness analyses of cancer therapies, and the evaluation of treatment options for COVID-19, indicating a strong focus on improving patient outcomes in cardiovascular and oncological contexts.
- Li conducted a network meta-analysis to assess the safety and effectiveness of PCSK9 inhibitors combined with statins, highlighting the need for systematic reviews and meta-analyses in emerging fields of pharmacotherapy.
- The research also explores innovative approaches in cancer treatment through the development of 3D-printed scaffolds for tumor management and detailed metabolic studies on seed germination, demonstrating a multidisciplinary approach that bridges plant science and medical applications.